Javascript must be enabled to continue!
Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic
View through CrossRef
Abstract
Background:
To date, four alternative splicing isoforms arising from exon skipping have been identified for α-Synuclein (α-Syn), the main constituent of the abnormal protein aggregation in Lewy bodies of Parkinson's disease (PD). In contrast to the full length,140 amino acid α-Syn (α-Syn 140), little is known about the splice isoforms' properties and functions. Small ubiquitin-like modification, SUMOylation, is a post-translational modification that regulates α-Syn function, aggregation, and degradation. There is limited information about α-Syn isoforms, their SUMOylation, and whether SUMOylation modulates these proteins' activity and fate. Therefore, this study has aimed to characterize the SUMOylation of α-Syn isoforms and its impact on cell death and α-Syn aggregation.
Results:
In a cellular model of PD induced by rotenone, cell toxicity, SUMOylation, and α-Syn aggregation with or without isoforms overexpression were evaluated in SH-SY5Y cells. First, we found that rotenone induced cell toxicity and α-Syn aggregation, associated with a significant reduction of SUMOylation and autophagy. Interestingly, boosting the SUMOylation machinery by overexpressing SUMO-1 prevented the α-Syn aggregation and phosphorylation and recovered the autophagy activity. The findings also revealed that α-Syn 140 and α-Syn 126 (lacks exon 3) were SUMOylated while the other two isoforms, α-Syn 112 and 98, arise from exon 3 and exon 3, 5 skipping respectively were not. Moreover, overexpressing the isoforms showed that those lacking exon 5 were more toxic and induced more α-Syn aggregation. Their toxicity was exacerbated in the presence of rotenone and was not affected by boosting the SUMOylation.
Conclusions:
These results show that the non-SUMOylated isoforms of α-Syn are more toxic and they may shed light on the role of SUMOylation machinery in modulating α-Syn aggregation also as pharmacological target and may set the stage for understanding more about the behavior of α-Syn isoforms.
Springer Science and Business Media LLC
Title: Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic
Description:
Abstract
Background:
To date, four alternative splicing isoforms arising from exon skipping have been identified for α-Synuclein (α-Syn), the main constituent of the abnormal protein aggregation in Lewy bodies of Parkinson's disease (PD).
In contrast to the full length,140 amino acid α-Syn (α-Syn 140), little is known about the splice isoforms' properties and functions.
Small ubiquitin-like modification, SUMOylation, is a post-translational modification that regulates α-Syn function, aggregation, and degradation.
There is limited information about α-Syn isoforms, their SUMOylation, and whether SUMOylation modulates these proteins' activity and fate.
Therefore, this study has aimed to characterize the SUMOylation of α-Syn isoforms and its impact on cell death and α-Syn aggregation.
Results:
In a cellular model of PD induced by rotenone, cell toxicity, SUMOylation, and α-Syn aggregation with or without isoforms overexpression were evaluated in SH-SY5Y cells.
First, we found that rotenone induced cell toxicity and α-Syn aggregation, associated with a significant reduction of SUMOylation and autophagy.
Interestingly, boosting the SUMOylation machinery by overexpressing SUMO-1 prevented the α-Syn aggregation and phosphorylation and recovered the autophagy activity.
The findings also revealed that α-Syn 140 and α-Syn 126 (lacks exon 3) were SUMOylated while the other two isoforms, α-Syn 112 and 98, arise from exon 3 and exon 3, 5 skipping respectively were not.
Moreover, overexpressing the isoforms showed that those lacking exon 5 were more toxic and induced more α-Syn aggregation.
Their toxicity was exacerbated in the presence of rotenone and was not affected by boosting the SUMOylation.
Conclusions:
These results show that the non-SUMOylated isoforms of α-Syn are more toxic and they may shed light on the role of SUMOylation machinery in modulating α-Syn aggregation also as pharmacological target and may set the stage for understanding more about the behavior of α-Syn isoforms.
Related Results
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Un manoscritto equivocato del copista santo Theophilos († 1548)
Un manoscritto equivocato del copista santo Theophilos († 1548)
<p><font size="3"><span class="A1"><span style="font-family: 'Times New Roman','serif'">ΕΝΑ ΛΑΝ&...
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Natural genetic variation and an alternative physiological state modify polyglutamine aggregation and toxicity in C. elegans
Natural genetic variation and an alternative physiological state modify polyglutamine aggregation and toxicity in C. elegans
Many human diseases are caused by mutations that induce misfolding and aggregation of the affected proteins, and are thought to result from failures in proteostasis. Pathways invol...
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
Animal models of Parkinson’s disease, in which the human α-synuclein transgene is overexpressed in the nigrostriatal pathway using viral vectors, are widely considered to be the mo...
Distinct cryo-EM Structure of α-synuclein Filaments derived by Tau
Distinct cryo-EM Structure of α-synuclein Filaments derived by Tau
Abstract
Recent structural studies of ex vivo amyloid filaments extracted from human patients demonstrated that the ex vivo filaments associated with different dise...
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
AbstractAccumulation of α-synuclein aggregates in the substantia nigra pars compacta is central in the pathophysiology of Parkinson’s disease, leading to the degeneration of dopami...
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
AbstractBackgroundNNI‐362 is a novel small molecule identified by phenotypic screening to discover compounds that promote new neurons from human neural progenitor cells and have ne...

